<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To investigate serum levels of <z:chebi fb="3" ids="37445">folate</z:chebi>, <z:chebi fb="13" ids="33611">B12</z:chebi>, and total <z:chebi fb="0" ids="17230">homocysteine</z:chebi> (tHcy) in elderly post-<z:hpo ids='HP_0001297'>stroke</z:hpo> patients, and the possible correlations with radiological markers of neuropathology </plain></SENT>
<SENT sid="1" pm="."><plain>DESIGN: Cross-sectional study </plain></SENT>
<SENT sid="2" pm="."><plain>SETTING: Department of Neurology, Cardinal Tien Hospital </plain></SENT>
<SENT sid="3" pm="."><plain>SUBJECTS: Eighty-nine elderly post-<z:hpo ids='HP_0001297'>stroke</z:hpo> patients were enrolled for dietary assessment and blood tests </plain></SENT>
<SENT sid="4" pm="."><plain>Neuroradiological assessment was done in 62 of these patients </plain></SENT>
<SENT sid="5" pm="."><plain>MAIN OUTCOME MEASURES: Dietary <z:chebi fb="3" ids="37445">folate</z:chebi> and <z:chebi fb="9" ids="17439">vitamin B12</z:chebi> intakes were evaluated by a 24-h recall system using a semi-quantitative questionnaire </plain></SENT>
<SENT sid="6" pm="."><plain>Circulating levels of <z:chebi fb="3" ids="37445">folate</z:chebi>, <z:chebi fb="13" ids="33611">B12</z:chebi>, and tHcy were measured </plain></SENT>
<SENT sid="7" pm="."><plain>Magnetic resonance imaging (MRI) or computed tomography (CT) was used for evaluation of <z:e sem="disease" ids="C0221505" disease_type="Disease or Syndrome" abbrv="">brain lesions</z:e> including infarction and <z:mpath ids='MPATH_127'>atrophy</z:mpath> </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS: Mean <z:chebi fb="3" ids="37445">folate</z:chebi> and <z:chebi fb="13" ids="33611">B12</z:chebi> intakes of these post-<z:hpo ids='HP_0001297'>stroke</z:hpo> patients were 69% and 261% of the recommended dietary allowances (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RDA</z:e>), respectively </plain></SENT>
<SENT sid="9" pm="."><plain>Inadequate <z:chebi fb="3" ids="37445">folate</z:chebi> levels, defined as serum <z:chebi fb="3" ids="37445">folate</z:chebi> &lt; 6 ng/mL, was noted in 68% of these patients </plain></SENT>
<SENT sid="10" pm="."><plain><z:e sem="disease" ids="C0598608" disease_type="Disease or Syndrome" abbrv="">Hyperhomocysteinemia</z:e> levels (tHcy &gt;or=15 micromol/L) were observed in 48% </plain></SENT>
<SENT sid="11" pm="."><plain>According to tertiles of serum tHcy and <z:chebi fb="3" ids="37445">folate</z:chebi> levels, the rate of brain <z:mpath ids='MPATH_127'>atrophy</z:mpath>, but not <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarctions</z:e>, are significantly associated with elevated tHcy (P = 0.0126) and decreased <z:chebi fb="3" ids="37445">folate</z:chebi> levels (P = 0.0273) </plain></SENT>
<SENT sid="12" pm="."><plain>After adjustments for age, sex, disease status, <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarctions</z:e> and <z:hpo ids='HP_0100546'>carotid stenosis</z:hpo>, the odds ratio of brain <z:mpath ids='MPATH_127'>atrophy</z:mpath> was 9.8 (95% CI: 1.7-56.4, P = 0.0101) in the <z:e sem="disease" ids="C0598608" disease_type="Disease or Syndrome" abbrv="">hyperhomocysteinemia</z:e> group and 9.6 (95% CI: 1.1-81.3, P = 0.0377) in the low <z:chebi fb="3" ids="37445">folate</z:chebi> group (serum <z:chebi fb="3" ids="37445">folate</z:chebi> &lt; 3.0 ng/mL) compared with the group with <z:mpath ids='MPATH_458'>normal</z:mpath> tHcy and <z:chebi fb="3" ids="37445">folate</z:chebi> levels </plain></SENT>
<SENT sid="13" pm="."><plain>No significant association was noted between <z:chebi fb="9" ids="17439">vitamin B12</z:chebi> levels and <z:e sem="disease" ids="C0221505" disease_type="Disease or Syndrome" abbrv="">brain lesions</z:e> </plain></SENT>
<SENT sid="14" pm="."><plain>CONCLUSIONS: Our data shows that <z:chebi fb="3" ids="37445">folate</z:chebi> deficiency and <z:e sem="disease" ids="C0598608" disease_type="Disease or Syndrome" abbrv="">hyperhomocysteinemia</z:e> are prevalent in elderly post-<z:hpo ids='HP_0001297'>stroke</z:hpo> patients </plain></SENT>
<SENT sid="15" pm="."><plain>These two conditions are strongly and independently associated with the development of brain <z:mpath ids='MPATH_127'>atrophy</z:mpath> </plain></SENT>
</text></document>